Literature DB >> 26819291

Successful heart transplant after 1374 days living with a total artificial heart.

Gino Gerosa1, Michele Gallo2, Tomaso Bottio2, Vincenzo Tarzia2.   

Abstract

The CardioWest Total Artificial Heart (CW-TAH) has been approved as a temporary device for bridge to cardiac transplantation and is under investigation for destination therapy by US Food and Drug Administration (FDA). We herein report the longest worldwide survival out of hospital (1374 days) of a patient supported with Cardio West Total Artificial Heart (CW-TAH). This experience is intended as a proof of concept of using CW-TAH as the destination therapy in patients with biventricular failure.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Cognitive profile; Destination therapy; Mechanical circulatory support; Quality of life; Total Artificial Heart

Mesh：

Year:  2016        PMID： 26819291     DOI： 10.1093/ejcts/ezv469

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN： 1010-7940            Impact factor:   4.191


  2 in total

1.  Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart.

Authors:  Muath Bishawi; Jun-Neng Roan; Jordan Richards; Zachary Brown; Laura Blue; Mani A Daneshmand; Jacob N Schroder; Dawn E Bowles; Carmelo A Milano
Journal:  J Vis Exp       Date:  2018-05-11       Impact factor: 1.355

2.  The HeartMate 6.

Authors:  Mani A Daneshmand; Muath Bishawi; Carmelo A Milano; Jacob N Schroder
Journal:  ASAIO J       Date:  2020-03       Impact factor: 3.826
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.